Former US FDA Commissioners’ Letter On Woodcock: Why This One Is Different Than Sharpless
Margaret Hamburg says selection process may move faster once Xavier Becerra is confirmed as HHS secretary since 'the chemistry of the relationship between the FDA commissioner and the HHS secretary is important.'
You may also be interested in...
Peter Marks says Acting Commissioner Janet Woodcock’s tenure running the FDA has been no different than if a permanent commissioner were in place.
Woodcock again defends the decision, saying Congress intended accelerated approval for those situations.
Patrizia Cavazzoni, who likely represents a somewhat different leadership style for CDER, distinguished herself while leading the center temporarily during the COVID-19 pandemic.